Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06HEY
|
||||
Former ID |
DNCL003454
|
||||
Drug Name |
CTL019
|
||||
Indication | Chronic lymphocytic leukaemia [ICD10:C91] | Phase 2 | [525190] | ||
Company |
Novartis Pharmaceuticals; University of Pennsylvania
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | Modulator | [551967] | |
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.